Matt TurnerPatient Affordability
Matthew DurhamOmnidynamic Marketing
Paul TheisenPatient Acquisition
Liz KaneImpactful Strategy
David LinetskyPoint-of-Care Marketing
Pat PurcellMeeting Engagement
Brenda SnowAuthentic Patient Voice
Stacey GandlerBrand Nourishment
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
Joey CohenMedication Adherence
Frank BurrellScientific Storytelling
Bud BilanichSuccess Coach
Amy GilesIncreasing Engagement
Investigational therapy crizanlizumab (SEG101, formerly SelG1) approximately doubled the time to first on-treatment sickle ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email